within Pharmacolibrary.Drugs.B_BloodAndBloodFormingOrgans.B05C_IrrigatingSolutions.B05CA01_Cetylpyridinium;

model Cetylpyridinium
  extends Pharmacolibrary.Pharmacokinetic.Models.PK_1C_enteral(
    weight = 70,
    F = 0.02,
    Cl = 2.777777777777778e-06,
    adminDuration = 600,
    adminMass = 2.0 / 1000000,
    adminCount = 1,
    Vd = 0.05,
    Cmin = 0.001,
    Cmax = 0.01,
    Ctox_peak = 0.02,
    Ctox_trough = 0.01,
    ka = 0.0016666666666666668,
    Tlag = 600);

  annotation (Documentation(
    info       = "<html><body><table><tr><td>name:</td><td>Cetylpyridinium</td></tr><tr><td>ATC code:</td><td>B05CA01</td></tr><td>route:</td><td>oral</td></tr>
    <tr><td>compartments:</td><td>1</td></tr>
    <tr><td>dosage:</td><td>2.0</td><td>mg</td></tr>
    <tr><td>volume of distribution:</td><td>50</td><td>L</td></tr>
    <tr><td>clearance:</td><td>10</td><td>L/h</td></tr>
    <tr><td colspan='3'>other parameters in model implementation</td></tr>
    </table><p>Cetylpyridinium is a quaternary ammonium compound with antiseptic properties, commonly used as a cationic surfactant and disinfectant. It is mainly used in oral care products such as mouthwashes and lozenges for its antibacterial activity against Gram-positive bacteria. Cetylpyridinium is not typically used systemically and lacks clinical approval for systemic therapeutic indications. It remains an approved agent in oral hygiene.</p><h4>Pharmacokinetics</h4><p>No published data available for human systemic pharmacokinetics. Systemic exposure is negligible due to local use and minimal absorption. Parameters are estimated based on physicochemical profile and assumptions.</p><h4>References</h4><ol><li><p>Matsuo, K, et al., &amp; Van Meerbeek, B (2019). Rechargeable anti-microbial adhesive formulation containing cetylpyridinium chloride montmorillonite. <i>Acta biomaterialia</i> 100 388–397. DOI:<a href=\"https://doi.org/10.1016/j.actbio.2019.09.045\">10.1016/j.actbio.2019.09.045</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/31568874/\">https://pubmed.ncbi.nlm.nih.gov/31568874</a></p></li><li><p>Kozak, KM, et al., &amp; White, DJ (2005). Efficacy of a high bioavailable cetylpyridinium chloride mouthrinse over a 24-hour period: a plaque imaging study. <i>American journal of dentistry</i> 18 Spec No 18A–23A. PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/16178132/\">https://pubmed.ncbi.nlm.nih.gov/16178132</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>10/2026 Pharmacolibrary 26.09: model of Drugs.ATC.B.B05CA01 folded in (Drugs.ATC removed)</li><li>06/2025 Tomas Kulhanek, generated model from data extracted from PUBMED, DrugBank and LLM(GPT4.1)</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
    
end Cetylpyridinium;
